Evidence map›Paper›PMID 35351239›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2022

Concomitant pulmonary disease is common among patients with extrapulmonary TB.

S V B Y Shivakumar, C Padmapriyadarsini, A Chavan, M Paradkar, B M Shrinivasa, A Gupte, K Dhanasekaran, B Thomas, N Suryavanshi, C K Dolla and 20 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Post-tuberculosis lung disease in treated extra-pulmonary tuberculosis.American journal of respiratory and critical care medicine · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 6 institutions in 3 countries.

S V B Y ShivakumarJohns Hopkins India, Pune, India.
C PadmapriyadarsiniIndian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, India.
A ChavanJohns Hopkins India, Pune, India, Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
M ParadkarJohns Hopkins India, Pune, India, Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
B M ShrinivasaIndian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, India.
A GupteJohns Hopkins School of Medicine, Baltimore, MD, USA.
K DhanasekaranIndian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, India.
B ThomasIndian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, India.
N SuryavanshiJohns Hopkins India, Pune, India, Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India, Johns Hopkins School of Medicine, Baltimore, MD, USA.
C K DollaIndian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, India.
S SelvarajuIndian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, India.
A KinikarByramjee Jeejeebhoy Government Medical College, Pune, India.
S GaikwadByramjee Jeejeebhoy Government Medical College, Pune, India.
R KohliJohns Hopkins India, Pune, India, Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
G N SivaramakrishnanIndian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, India.
N PradhanJohns Hopkins India, Pune, India, Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
L E HannaIndian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, India.
V KulkarniJohns Hopkins India, Pune, India, Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
A DeLucaJohns Hopkins School of Medicine, Baltimore, MD, USA.
S R CoxJohns Hopkins School of Medicine, Baltimore, MD, USA.
L MuraliDistrict Tuberculosis Office, Thiruvallur, India.
K ThiruvengadamIndian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, India.
S RaskarJohns Hopkins India, Pune, India, Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
G RamachandranIndian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, India.
J E GolubJohns Hopkins School of Medicine, Baltimore, MD, USA, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
N GupteJohns Hopkins India, Pune, India, Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India, Johns Hopkins School of Medicine, Baltimore, MD, USA.
V MaveJohns Hopkins India, Pune, India, Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India, Johns Hopkins School of Medicine, Baltimore, MD, USA.
S SwaminathanWorld Health Organization, Geneva, Switzerland.
A GuptaJohns Hopkins School of Medicine, Baltimore, MD, USA, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
R C BollingerJohns Hopkins School of Medicine, Baltimore, MD, USA, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Johns Hopkins University · USIndian Council of Medical Research · INGovernment Medical College · INNational Institute of Research in Tuberculosis · INGovernment Medical College · INWorld Health Organization · CH

Funding

The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)UM1AI069465 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Charles W. Flexner, Amita Gupta · 2012 to 2026
$34.1M
The Impact of Diabetes on TB treatment outcomesR01AI097494 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GOLUB, JONATHAN E. · 2013 to 2017
$3.0M
HIV-TB Fogarty Research Training ProgramD43TW009574 · FIC · JOHNS HOPKINS UNIVERSITY · PI BOLLINGER, ROBERT C. · 2013 to 2017
$1.0M
FIC NIH HHS D43 TW009574NIAID NIH HHS R01 AI097494NIAID NIH HHS UM1 AI069465World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

TuberculosisTuberculosis, PulmonaryAdultChildCoughHumansIndiaSputum

Identifiers

PMID35351239
PMCPMC8982647
OpenAlexW4221134451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.